Zobrazeno 1 - 10
of 17 121
pro vyhledávání: '"Pharmacology And Pharmaceutical Sciences"'
Publikováno v:
Current Drug Delivery. 20:1031-1036
Abstract: Nanomedicines have been used over time because of their significant impact on human health care for the prevention, early detection, diagnosis, treatment, and follow-up of a wide range of illnesses. Nanomedicines must be adequately characte
Autor:
Xing-Qiang Dong, Li-Kai Chu, Xu Cao, Qian-Wei Xiong, Yi-Ming Mao, Ching-Hsien Chen, Yun-Li Bi, Jun Liu, Xiang-Ming Yan
Publikováno v:
Redox report : communications in free radical research, vol 28, iss 1
Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30cb6cf91b294781b3a3dde3ca998fd0
https://escholarship.org/uc/item/72n5h69w
https://escholarship.org/uc/item/72n5h69w
Publikováno v:
Infection and Drug Resistance. 16:2709-2726
Bacterial and fungal infections are common issues for patients in the intensive care unit (ICU). Large, multinational point prevalence surveys have identified that up to 50% of ICU patients have a diagnosis of bacterial or fungal infection at any one
Publikováno v:
Journal of pharmacological sciences, vol 152, iss 1
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is caused when Spike-protein (S-protein) present on the surface of SARS-CoV-2 interacts with human cell surface receptor,
Autor:
Asif Ahmad Bhat, Riya Thapa, Ahsas Goyal, Vetriselvan Subramaniyan, Deepak Kumar, Saurabh Gupta, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta
Publikováno v:
Future Medicinal Chemistry. 15:583-586
Autor:
Conor B. O’Herin, Yuta W. Moriuchi, Troy A. Bemis, Alysia J. Kohlbrand, Michael D. Burkart, Seth M. Cohen
Publikováno v:
Journal of medicinal chemistry, vol 66, iss 4
Human carbonic anhydrase II (hCAII) is a metalloenzyme essential to critical physiological processes in the body. hCA inhibitors are used clinically for the treatment of indications ranging from glaucoma to epilepsy. Targeted protein degraders have e
Autor:
Nikitin, Dmitriy, Makam, Anil N, Suh, Kangho, McKenna, Avery, Carlson, Josh J, Richardson, Marina, Rind, David M, Pearson, Steven D
Publikováno v:
Journal of managed care & specialty pharmacy, vol 29, iss 2
DISCLOSURES: Funding for this summary was contributed by Blue Cross Blue Shield of MA, California Healthcare Foundation, The Patrick and Catherine Weldon Donaghue Medical Research Foundation, Arnold Ventures, and Kaiser Foundation Health Plan Inc., t
Impact of Smoking Status and Nicotine Dependence on Academic Performance of Health Sciences Students
Autor:
Jaber S Alqahtani, Abdulelah M Aldhahir, Zaid Alanazi, Emad Zahi Alsulami, Mujahid A Alsulaimani, Abdullah A Alqarni, Abdullah S Alqahtani, Ayadh Yahya AlAyadi, Musallam Alnasser, Ibrahim A AlDraiwiesh, Saeed M Alghamdi, Hussam M Almarkhan, Abdullah S Alsulayyim, Saad M AlRabeeah, Mohammed D AlAhmari
Publikováno v:
Substance Abuse and Rehabilitation. 14:13-24
Jaber S Alqahtani,1 Abdulelah M Aldhahir,2 Zaid Alanazi,3 Emad Zahi Alsulami,4 Mujahid A Alsulaimani,5 Abdullah A Alqarni,6 Abdullah S Alqahtani,1 Ayadh Yahya AlAyadi,1 Musallam Alnasser,1 Ibrahim A AlDraiwiesh,1 Saeed M Alghamdi,7 Hussam M Almarkhan
Autor:
Ryjul W. Stokes, Alysia J. Kohlbrand, Hyeonglim Seo, Banumathi Sankaran, Johannes Karges, Seth M. Cohen
Publikováno v:
ACS medicinal chemistry letters, vol 14, iss 1
Among the most important influenza virus targets is the RNA-dependent RNA polymerase acidic N-terminal (PAN) endonuclease, which is a critical component of the viral replication machinery. To inhibit the activity of this metalloenzyme, small-molecule
Autor:
Tri Indah Winarni, Tanjung Ayu Sumekar, Widodo Sarjana, Hardian Hardian, Randi J Hagerman, Sultana MH Faradz
Publikováno v:
Intractable Rare Dis Res
Intractable & rare diseases research, vol 11, iss 4
Intractable & rare diseases research, vol 11, iss 4
Fragile X syndrome (FXS) is caused by the full mutation in the fragile x messenger ribonucleoprotein 1 (FMR1) gene leading to the absence of the fragile X protein (FXP). Previous studies show that individuals with FXS exhibit changing behavior over t